| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| NEUTRAL | SELL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 1.17▲ | 1.15▲ | 1.16▲ | 1.20▼ | 1.27▼ |
| MA10 | 1.16▲ | 1.16▲ | 1.17▼ | 1.23▼ | 1.34▼ |
| MA20 | 1.17▲ | 1.19▼ | 1.20▼ | 1.28▼ | 1.46▼ |
| MA50 | 1.21▼ | 1.23▼ | 1.24▼ | 1.38▼ | 1.89▼ |
| MA100 | 1.23▼ | 1.28▼ | 1.32▼ | 1.52▼ | 2.05▼ |
| MA200 | 1.30▼ | 1.36▼ | 1.39▼ | 1.88▼ | N/A |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.004▲ | -0.001▼ | -0.003▼ | -0.006▼ | -0.011▼ |
| RSI | 46.497▼ | 43.572▼ | 42.305▼ | 33.224▼ | 35.312▼ |
| STOCH | 49.167 | 16.667▼ | 22.037 | 20.480 | 18.122▼ |
| WILL %R | -40.000 | -66.667 | -66.667 | -78.000▼ | -89.815▼ |
| CCI | 27.273 | 9.419 | -30.668 | -218.162▼ | -177.377▼ |
|
Thursday, September 03, 2026 06:54 AM
ImmunityBio looks attractive due to ANKTIVA's FDA approval for BCG-unresponsive NMIBC and pipeline expansion potential. See why I rate IBRX stock a Buy.
|
|
Thursday, August 20, 2026 07:30 AM
Track conference calls, annual meetings, summits, analyst days and other corporate events scheduled for Binah Capital Group Inc. Use the full market events calendar to scan activity across all tickers ...
|
|
Thursday, August 13, 2026 07:47 AM
BCG Leader Daniel Friedman joins Kristen Scholer on NYSE Live to discuss the M&A market after gains ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 24/09/26 | 1.16 | 1.165 | 1.11 | 1.165 | 26,831 |
| 23/09/26 | 1.20 | 1.239 | 1.16 | 1.18 | 45,310 |
| 22/09/26 | 1.2101 | 1.25 | 1.21 | 1.23 | 8,307 |
| 21/09/26 | 1.22 | 1.265 | 1.21 | 1.24 | 29,976 |
| 18/09/26 | 1.2594 | 1.2594 | 1.20 | 1.20 | 10,196 |
| 17/09/26 | 1.2966 | 1.2966 | 1.2421 | 1.2647 | 3,157 |
| 16/09/26 | 1.251 | 1.2929 | 1.2412 | 1.25 | 4,640 |
| 15/09/26 | 1.27 | 1.29 | 1.25 | 1.26 | 14,202 |
| 14/09/26 | 1.30 | 1.32 | 1.25 | 1.26 | 18,311 |
| 11/09/26 | 1.2402 | 1.28 | 1.22 | 1.28 | 24,947 |
|
|
||||
|
|
||||
|
|